Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
Upgrade Now
Claim MarketBeat All Access Sale Promotion

HUTCHMED (HCM) Financials

HUTCHMED logo
$12.08 +0.17 (+1.39%)
As of 02:46 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for HUTCHMED

Annual Income Statements for HUTCHMED

This table shows HUTCHMED's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -35 12 -27 -75 -106 -126 -195 -361 101 38 457
Consolidated Net Income / (Loss)		 10 15 -23 -71 -104 -116 -167 -360 101 38 458
Net Income / (Loss) Continuing Operations		 10 15 -23 -71 -104 -116 -167 -360 101 38 458
Total Pre-Tax Income 		-11 -47 -54 -87 -141 -190 -216 -410 58 -1.11 499
Total Operating Income		 -9.77 -47 -53 -93 -146 -197 -328 -408 18 -44 -39
Total Gross Profit		 73 60 65 70 45 39 98 115 454 281 212
Total Revenue		 178 216 241 214 205 228 356 426 838 630 549
Operating Revenue		 178 216 241 214 - - 356 426 838 630 549
Total Cost of Revenue		 105 156 176 144 160 189 258 311 384 349 336
Operating Cost of Revenue		 105 156 176 144 160 189 258 311 384 349 336
Total Operating Expenses		 83 106 119 163 191 236 426 523 435 325 251
Selling, General & Admin Expense		 30 40 43 49 53 61 127 136 133 113 103
Research & Development Expense		 47 67 76 114 138 175 299 387 302 212 148
Total Other Income / (Expense), net		 -0.77 -0.66 -0.12 5.99 5.28 6.93 113 -2.73 40 43 538
Interest Expense		 1.40 1.63 1.46 1.01 1.03 0.79 0.59 0.65 0.76 2.87 2.87
Interest & Investment Income		 0.45 0.50 1.22 5.98 4.94 3.24 123 9.60 36 40 527
Other Income / (Expense), net		 0.18 0.47 0.12 1.02 1.37 4.49 -10 -12 4.55 5.39 14
Income Tax Expense		 1.61 4.33 3.08 3.96 3.27 4.83 12 -0.28 4.51 7.19 64
Other Gains / (Losses), net		 23 66 34 19 41 79 61 50 47 46 23
Net Income / (Loss) Attributable to Noncontrolling Interest		 45 2.86 3.77 3.52 2.35 10 28 0.45 0.31 0.44 0.82
Basic Earnings per Share		 ($0.64) $0.20 ($0.04) ($0.11) ($0.16) ($0.18) ($0.25) ($0.43) $0.12 $0.04 $0.53
Weighted Average Basic Shares Outstanding		 54.66M 59.72M 617.17M 664.26M 665.68M 697.93M 792.68M 847.14M 849.65M 855.35M 858.28M
Diluted Earnings per Share		 ($0.64) $0.20 ($0.04) ($0.11) ($0.16) ($0.18) ($0.25) ($0.43) $0.12 $0.04 $0.52
Weighted Average Diluted Shares Outstanding		 54.66M 59.97M 617.17M 664.26M 665.68M 697.93M 792.68M 847.14M 869.20M 872.83M 872.89M
Weighted Average Basic & Diluted Shares Outstanding		 - 60.71M 617.17M 664.26M 665.68M 697.93M 864.53M 864.78M 871.26M 871.60M 872.33M

Quarterly Income Statements for HUTCHMED

No quarterly income statements for HUTCHMED are available.

Annual Cash Flow Statements for HUTCHMED

This table details how cash moves in and out of HUTCHMED's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -7.01 57 15 34 116 177 346 204 -249 -130 -18
Net Cash From Operating Activities		 -9.39 -9.57 -8.94 -33 -81 -62 -204 -269 219 0.50 -65
Net Cash From Continuing Operating Activities		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Income / (Loss) Continuing Operations		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Investing Activities		 8.86 -34 -261 44 119 -125 -306 297 -291 -96 -29
Net Cash From Continuing Investing Activities		 8.86 -34 -261 44 119 -125 -306 297 -291 -96 -29
Purchase of Property, Plant & Equipment		 -3.32 -4.33 -5.02 -6.36 -8.57 -7.95 -16 -37 -33 -18 -14
Acquisitions		 0.00 -5.00 -7.00 -8.00 8.69 - 0.00 0.00 -8.09 0.00 -10
Purchase of Investments		 0.00 -81 -325 -904 -478 -733 -1,356 -1,202 -1,628 -1,849 -2,742
Sale of Property, Plant & Equipment		 - - - - - - - - 0.00 0.00 0.03
Divestitures		 - - 0.00 - 0.00 - 0.00 0.00 35 0.00 609
Sale and/or Maturity of Investments		 12 57 76 962 597 629 921 1,518 1,343 1,769 2,128
Other Investing Activities, net		 - - - 0.00 0.00 -14 145 17 0.00 1.28 0.00
Net Cash From Financing Activities		 -5.47 92 273 -8.23 -1.49 296 650 -83 49 -31 7.84
Net Cash From Continuing Financing Activities		 -5.47 92 273 -8.23 -1.49 296 650 -83 49 -31 7.84
Repayment of Debt		 -6.41 -29 -49 -32 -27 0.00 -0.58 -27 0.00 -31 -25
Repurchase of Common Equity		 -3.11 -14 -9.94 -6.19 -0.35 -21 -57 -48 -9.07 -36 0.00
Payment of Dividends		 -0.59 -0.56 -1.59 -1.28 -1.28 -1.46 -9.89 -26 -9.07 -1.00 0.00
Issuance of Debt		 3.21 25 33 27 27 0.00 0.00 18 62 36 31
Issuance of Common Equity		 1.37 111 302 3.87 0.25 319 717 0.17 5.09 0.79 1.58
Effect of Exchange Rate Changes		 -7.01 -1.78 2.36 -1.90 -1.50 5.55 2.43 -9.49 -6.47 -3.40 3.60
Cash Interest Paid		 1.22 1.57 0.76 0.98 0.92 0.82 0.43 0.15 0.42 2.51 2.52
Cash Income Taxes Paid		 0.51 2.66 3.84 3.75 3.25 5.94 5.01 19 3.73 3.59 62

Quarterly Cash Flow Statements for HUTCHMED

No quarterly cash flow statements for HUTCHMED are available.

Annual Balance Sheets for HUTCHMED

This table presents HUTCHMED's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 230 342 598 532 465 724 1,373 1,029 1,280 1,274 1,753
Total Current Assets		 90 167 432 371 317 531 1,212 840 1,097 1,067 1,567
Cash & Equivalents		 32 79 85 86 121 236 378 313 284 154 71
Short-Term Investments		 0.00 24 273 215 96 200 634 318 603 682 1,296
Note & Lease Receivable		 - - - - - - - 0.00 0.00 0.00 0.00
Accounts Receivable		 48 46 51 44 68 48 84 99 145 163 137
Inventories, net		 9.56 13 12 12 16 20 36 57 50 50 41
Other Current Assets		 - 4.31 11 13 16 28 81 53 15 17 22
Plant, Property, & Equipment, net		 8.51 9.95 14 17 21 24 41 76 100 92 95
Total Noncurrent Assets		 132 165 152 145 127 169 119 114 83 115 91
Long-Term Investments		 120 159 144 138 99 140 76 74 48 83 11
Noncurrent Note & Lease Receivables		 1.34 1.22 1.26 1.17 16 - - - - 0.00 0.00
Goodwill		 3.33 3.14 3.31 3.19 - - - - - 2.99 3.11
Noncurrent Deferred & Refundable Income Taxes		 - 0.00 0.63 0.58 0.82 1.52 9.40 15 15 12 13
Other Noncurrent Operating Assets		 6.58 1.77 1.65 1.36 11 28 33 24 19 17 65
Total Liabilities & Shareholders' Equity		 230 342 598 532 465 724 1,373 1,029 1,280 1,274 1,753
Total Liabilities		 127 138 113 120 152 205 333 393 536 502 502
Total Current Liabilities		 81 95 105 85 113 158 312 354 403 377 316
Short-Term Debt		 23 20 30 - - 0.00 27 0.00 31 23 25
Accounts Payable		 57 41 31 26 24 32 41 71 36 43 46
Current Deferred Revenue		 1.17 0.96 1.30 2.54 2.11 - - 13 58 50 31
Current Deferred & Payable Income Tax Liabilities		 0.31 1.64 0.98 0.56 1.83 1.12 16 1.11 2.58 1.55 2.08
Other Current Liabilities		 - 32 41 56 85 126 228 268 275 259 212
Total Noncurrent Liabilities		 46 43 8.37 34 39 47 21 39 133 126 186
Long-Term Debt		 27 27 0.00 27 27 27 0.00 18 48 59 68
Noncurrent Deferred Revenue		 5.63 4.30 2.80 0.41 0.13 - - 0.19 69 48 20
Noncurrent Deferred & Payable Income Tax Liabilities		 3.42 4.00 4.45 4.84 3.16 5.06 2.77 2.71 1.48 2.99 0.26
Other Noncurrent Operating Liabilities		 10 8.13 1.12 2.40 9.01 15 19 18 14 15 97
Commitments & Contingencies		 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 102 204 485 412 313 519 1,040 637 743 772 1,251
Total Preferred & Common Equity		 83 184 462 389 288 484 987 610 731 760 1,238
Total Common Equity		 83 184 462 389 288 484 987 610 731 760 1,238
Common Stock		 170 269 563 572 582 895 1,592 1,584 1,610 1,605 1,621
Retained Earnings		 -92 -80 -107 -183 -290 -416 -610 -971 -871 -833 -379
Accumulated Other Comprehensive Income / (Loss)		 5.02 -4.28 5.43 -0.24 -3.85 4.48 5.57 -1.90 -8.16 -12 -4.53
Noncontrolling Interest		 19 20 23 23 25 35 53 27 13 12 13

Quarterly Balance Sheets for HUTCHMED

No quarterly balance sheets for HUTCHMED are available.

Annual Metrics And Ratios for HUTCHMED

This table displays calculated financial ratios and metrics derived from HUTCHMED's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - - - - 872,327,620.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 872,327,620.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.52
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -6.84 -33 -37 -65 -102 -138 -230 -285 17 -31 -34
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -43.57% 2.06% -3.58% -2.54%
Earnings before Interest and Taxes (EBIT)		 -9.59 -46 -53 -92 -145 -192 -339 -419 23 -38 -25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -9.59 -46 -53 -92 -145 -192 -339 -419 23 -38 -25
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -7.26 -21 -61 -52 -126 -85 -237 -257 79 -78 -65
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.43 -11 12 -0.28 24 -29 -22 -50 -112 -64 -34
Increase / (Decrease) in Invested Capital		 0.43 -12 24 -13 24 -52 7.11 -28 -62 48 30
Book Value per Share		 $1.53 $3.09 $7.61 $5.85 $4.32 $0.69 $1.36 $0.71 $0.84 $0.87 $1.42
Tangible Book Value per Share		 $1.45 $3.03 $7.54 $5.80 $4.32 $0.69 $1.36 $0.71 $0.84 $0.87 $1.42
Total Capital		 152 251 515 439 340 546 1,066 655 823 855 1,344
Total Debt		 50 47 30 27 27 27 27 18 79 83 93
Total Long-Term Debt		 27 27 0.00 27 27 27 0.00 18 48 59 68
Net Debt		 -102 -215 -473 -413 -289 -548 -1,061 -687 -855 -836 -1,285
Capital Expenditures (CapEx)		 3.32 4.33 5.02 6.36 8.57 7.95 16 37 33 18 14
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.41 -11 -0.71 -16 -13 -63 -84 -145 -161 -123 -91
Debt-free Net Working Capital (DFNWC)		 32 92 358 285 204 372 927 486 725 713 1,277
Net Working Capital (NWC)		 8.45 72 328 285 204 372 900 486 694 690 1,252
Net Nonoperating Expense (NNE)		 -17 -47 -14 6.44 1.21 -22 -63 75 -84 -69 -492
Net Nonoperating Obligations (NNO)		 -102 -215 -473 -413 -289 -548 -1,061 -687 -855 -836 -1,285
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.43) ($1.13) ($0.16) ($0.18) ($0.25) ($0.43) $0.12 $0.04 $0.53
Adjusted Weighted Average Basic Shares Outstanding		 0.00 59.72M 61.72M 66.43M 666.91M 727.72M 792.68M 847.14M 849.65M 855.35M 858.28M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.43) ($1.13) ($0.16) ($0.18) ($0.25) ($0.43) $0.12 $0.04 $0.52
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 59.97M 61.72M 66.43M 666.91M 727.72M 792.68M 847.14M 869.20M 872.83M 872.89M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($0.16) ($0.18) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 60.71M 66.45M 66.66M 665.68M 697.93M 864.53M 864.78M 871.26M 871.60M 872.33M
Normalized Net Operating Profit after Tax (NOPAT)		 -6.84 -33 -37 -65 -102 -138 -230 -285 17 -31 -34
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for HUTCHMED

No quarterly metrics and ratios for HUTCHMED are available.


Financials Breakdown Chart

HUTCHMED Financials - Frequently Asked Questions

According to the most recent income statement we have on file, HUTCHMED's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

HUTCHMED's net income appears to be on a downward trend, with a most recent value of $457.73 million in 2025, rising from $10.43 million in 2015. The previous period was $38.17 million in 2024. Check out HUTCHMED's forecast to explore projected trends and price targets.

HUTCHMED's total operating income in 2025 was -$39.16 million, based on the following breakdown:
  • Total Gross Profit: $212.16 million
  • Total Operating Expenses: $251.32 million

Over the last 10 years, HUTCHMED's total revenue changed from $178.20 million in 2015 to $548.51 million in 2025, a change of 207.8%.

HUTCHMED's total liabilities were at $501.84 million at the end of 2025, a 0.1% decrease from 2024, and a 294.1% increase since 2015.

In the past 10 years, HUTCHMED's cash and equivalents has ranged from $31.94 million in 2015 to $377.54 million in 2021, and is currently $71.33 million as of their latest financial filing in 2025.

Over the last 10 years, HUTCHMED's book value per share changed from 1.53 in 2015 to 1.42 in 2025, a change of -6.9%.


Related Companies

Financial statements for NASDAQ:HCM last updated on 3/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel